(Q41329890)

29 September 2017

Synthesis of 1'-C-cyano pyrimidine nucleosides and characterization as HCV polymerase inhibitors (English)

1 reference

29 September 2017

10

1 reference

29 September 2017

9

Aesop Cho

1 reference

29 September 2017

Thorsten A Kirschberg

1

object named as

Thorsten A Kirschberg

1 reference

29 September 2017

6

Sammy Metobo

1 reference

29 September 2017

4

Sebastian Zonte

1 reference

29 September 2017

Michael Mish

2

1 reference

29 September 2017

Neil H Squires

3

1 reference

29 September 2017

Evangelos Aktoudianakis

5

1 reference

29 September 2017

Thomas Butler

7

1 reference

29 September 2017

Xie Ju

8

1 reference

29 September 2017

Choung U Kim

11

1 reference

29 September 2017

23 September 2015

1 reference

Nucleosides, Nucleotides & Nucleic Acids

29 September 2017

1 reference

29 September 2017

34

1 reference

29 September 2017

11

1 reference

29 September 2017

763-785

1 reference

The hepatitis C virus life cycle as a target for new antiviral therapies

29 September 2017

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2015.1075550

Chutes and ladders in hepatitis C nucleoside drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2015.1075550

Design, synthesis and evaluation of a novel double pro-drug: INX-08189. A new clinical candidate for hepatitis C virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2015.1075550

Safety and pharmacokinetics of IDX184, a liver-targeted nucleotide polymerase inhibitor of hepatitis C virus, in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2015.1075550

Nucleoside, nucleotide, and non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA-polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2015.1075550

Preparation and biological evaluation of 1'-cyano-2'-C-methyl pyrimidine nucleosides as HCV NS5B polymerase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2015.1075550

Discovery of the first C-nucleoside HCV polymerase inhibitor (GS-6620) with demonstrated antiviral response in HCV infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2015.1075550

2'-Deoxy-2'-spirocyclopropylcytidine revisited: a new and selective inhibitor of the hepatitis C virus NS5B polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2015.1075550

Inhibition of hepatitis C virus RNA replication by 2'-modified nucleoside analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2015.1075550

Synthesis and cytokine modulation properties of pyrrolo[2, 3-d]-4-pyrimidone nucleosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2015.1075550

2'-deoxy-4'-azido nucleoside analogs are highly potent inhibitors of hepatitis C virus replication despite the lack of 2'-alpha-hydroxyl groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2015.1075550

Synthesis of 2'-C-beta-methyl-2'-deoxyguanosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2015.1075550

Application of kinase bypass strategies to nucleoside antivirals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2015.1075550

Nucleotide prodrugs for HCV therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2015.1075550

Synthesis and characterization of 2'-C-Me branched C-nucleosides as HCV polymerase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2015.1075550

Mechanism of activation of PSI-7851 and its diastereoisomer PSI-7977

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2015.1075550

Aryl phosphoramidate derivatives of d4T have improved anti-HIV efficacy in tissue culture and may act by the generation of a novel intracellular metabolite.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2015.1075550

Synthesis of diastereomerically pure nucleotide phosphoramidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2015.1075550

Synthesis and antiviral activity of a series of 1'-substituted 4-aza-7,9-dideazaadenosine C-nucleosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2015.1075550

10.1080/15257770.2015.1075550

21 January 2018

Identifiers

DOI

1 reference

29 September 2017

1 reference